Astrana Health (ASTH) Set to Announce Earnings on Thursday

Astrana Health (NASDAQ:ASTH) will be releasing its earnings data after the market closes on Thursday, November 7th. Analysts expect Astrana Health to post earnings of $0.33 per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Wednesday, August 7th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.01. The company had revenue of $486.30 million for the quarter, compared to the consensus estimate of $440.68 million. Astrana Health had a net margin of 4.30% and a return on equity of 10.71%. The company’s revenue was up 39.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.28 EPS. On average, analysts expect Astrana Health to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Astrana Health Stock Performance

Shares of Astrana Health stock opened at $56.00 on Wednesday. Astrana Health has a 12 month low of $28.86 and a 12 month high of $63.20. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.62. The stock has a market cap of $2.75 billion, a PE ratio of 38.89, a price-to-earnings-growth ratio of 2.08 and a beta of 1.24. The business has a fifty day simple moving average of $55.07 and a 200-day simple moving average of $47.23.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Truist Financial lifted their target price on Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research note on Friday, August 9th. TD Cowen assumed coverage on shares of Astrana Health in a research note on Monday, October 14th. They issued a “buy” rating and a $66.00 price objective on the stock. Stifel Nicolaus lifted their target price on shares of Astrana Health from $48.00 to $60.00 and gave the company a “buy” rating in a research note on Thursday, August 1st. BTIG Research upped their price target on shares of Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research note on Thursday, October 3rd. Finally, Robert W. Baird lifted their price objective on Astrana Health from $54.00 to $67.00 and gave the company an “outperform” rating in a research report on Thursday, August 15th. One investment analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $62.00.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.